There is currently no comprehensive report on the potential expression of the ARFs gene family in pan-cancer, as well as the clinical relevance and possible molecular regulatory mechanisms of ARF5 in cancer, especially in hepatocellular carcinoma (HCC). The gene discussed is ARF5; the disease is hepatocellular carcinoma.